Purdue Pharma and the billionaire Sackler family may leverage profits from OxyContin as part of an unusual proposed resolution to 2,000 lawsuits accusing them of driving the opioid epidemic

Follow your first journalist

Create a free Journa account

Search and follow 52.983 automatically recognized authors and receive the latest news of the journalists you follow in a convenient newsfeed and in your inbox. Want to know more?

Already have an account? Log in with Linkedin

Are you a journalist? Create a profile

By signing up you agree to the terms and conditions and the privacy policy.

Article

Emma Court for Business Insider

Aug 28 ’19

Purdue Pharma and the billionaire Sackler family may leverage profits from OxyContin as part of an unusual proposed resolution to 2,000 lawsuits accusing them of driving the opioid epidemic

We found this article at:

www.businessinsider.nl/purdue-sackler-opioid-settlement-could-turn-purdue-to-public-trust-2019-8/

Follow your first journalist

Create a free Journa account

Article

Purdue Pharma and the billionaire Sackler family may leverage profits from OxyContin as part of an unusual proposed resolution to 2,000 lawsuits accusing them of driving the opioid epidemic

auteur

Get notified of new articles from this auteur

Emma Court